Corvus Pharmaceuticals, Inc.
CRVSPharmaceutical Preparations · SIC 2834 · CIK 0001626971
Revenue FY2025
—
Net Income
$(15.0M)
EPS (Basic)
$-0.19
Net Margin
—
ROE
-25.0%
Total Equity
$61.0M
Shares Out
84M
Corvus Pharmaceuticals, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2015–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 5 funds in our universe
Insider Transactions
Reading stored insider transactions…